Zone 3 senescent hepatocytes regulate hypoxic preconditioning via exosomal miR-210, and their premature removal exacerbates reperfusion injury

Hypothesis

Senescent hepatocytes residing in the pericentral (zone 3) liver actively secrete exosomes enriched in miR-210 that stabilize HIF‑1α in neighboring parenchymal and non‑parenchymal cells, thereby establishing a transient hypoxic preconditioning state that protects against subsequent ischemic/reperfusion injury. Premature senolytic clearance of these zone‑3 senescent cells abolishes this exosomal miR‑210 transfer, diminishing HIF‑1α signaling and rendering the liver more vulnerable to reperfusion damage.

Mechanistic Basis

• Zone 3 hepatocytes experience low oxygen tension, high Wnt/β‑catenin signaling, and lipotoxic stress, promoting senescence accumulation [4].
• Senescent cells exhibit a senescence‑associated secretory phenotype (SASP) that includes IL‑6, CXCL2, TGF‑β, and THBS1 [1].
• Recent work shows senescent cholangiocytes can disseminate senescence via paracrine TGF‑β [3], suggesting senescent hepatocytes may similarly export regulatory molecules.
• miR‑210 is a well‑characterized hypoxia‑responsive miRNA that inhibits iron‑sulfur cluster assembly proteins (e.g., ISCU) and promotes HIF‑1α stability [2]
• Exosomal miR‑210 transfer from stressed or senescent cells has been demonstrated in other tissues to confer hypoxia tolerance.

We propose that zone‑3 senescent hepatocytes load miR‑210 into exosomes as part of a protective SASP arm, distinct from the pro‑fibrotic TGF‑β/THBS1 axis. This exosomal cargo diffuses to adjacent hepatocytes and hepatic stellate cells, lowering oxidative phosphorylation, reducing ROS production, and activating HIF‑1α target genes (e.g., EPO, VEGF, GLUT1) that pre‑condition the lobule against impending hypoxic insult.

Predictions

1. Exosomal miR‑210 enrichment: Isolating exosomes from livers of young mice after acute CCl4 injury will show higher miR‑210 levels compared with uninjured controls; this enrichment will be lost in mice treated with senolytics (D+Q) prior to exosome collection.
2. HIF‑1α activation: Co‑culture of naïve hepatocytes with exosomes from senescent zone‑3 hepatocytes will increase HIF‑1α protein and downstream target expression; neutralizing miR‑210 with antagomiRs will abrogate this effect.
3. Functional preconditioning: Mice receiving exosomes from senescent zone‑3 hepatocytes prior to ischemia/reperfusion (I/R) will exhibit reduced serum ALT/AST, lower necrotic area, and improved survival compared with mice receiving exosomes from non‑senescent hepatocytes or exosome‑depleted supernatant.
4. Senolytic timing: Administering senolytics after the peak of exosomal miR‑210 release (e.g., 48 h post‑injury) will preserve the protective effect while still reducing fibrotic SASP, whereas early senolytic treatment (≤12 h post‑injury) will exacerbate I/R injury.
5. Spatial restriction: miR‑210 signal will be strongest in zone 3 and decay toward the periportal area, mirroring the hemodynamic gradient that drives zone‑3 senescence.

Experimental Design

• Model: Use C57BL/6 mice subjected to acute CCl4-induced liver injury to induce transient senescence; administer D+Q at defined times.
• Exosome isolation: Differential ultracentrifugation from liver perfusate; characterize by NTA, CD63/CD81 Western blot.
• miRNA profiling: qRT‑PCR for miR‑210 and other SASP‑related miRNAs.
• In vitro assays: Primary hepatocytes exposed to isolated exosomes; measure HIF‑1α (Western), ROS (DCFDA), and cell viability after hypoxia/reoxygenation.
• In vivo I/R: Partial portal vein occlusion for 45 min followed by reperfusion; assess injury markers, histology, and survival.
• Controls: Exosomes from senescence‑free livers, miR‑210‑antagomiR‑treated exosomes, and TGF‑β neutralizing antibodies to distinguish SASP arms.

Falsifiability

If exosomal miR‑210 from zone‑3 senescent hepatocytes does not enhance HIF‑1α signaling in neighboring cells, or if senolytic clearance fails to worsen I/R injury despite loss of miR‑210, the hypothesis would be refuted. Conversely, demonstrating that restoring miR‑210 (via synthetic exosomes) rescues the protective effect in senolytic‑treated mice would strongly support the proposed mechanism.